FMP
NASDAQ
4.06 USD
0.01 (0.25%)
Mr. Shawn K. Singh J.D.
Healthcare
Biotechnology
https://www.vistagen.com
NASDAQ
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also compris...
0001411685
US92840H4002
92840H202
343 Allerton Avenue
650 577 3600
US
37
Jun 21, 2011
0001411685
NASDAQ
Biotechnology
Healthcare
92840H202
US92840H4002
US
4.06
0.78
306.47k
109.72M
-
1.62-24.71
1.98
-
-
-
-
-1.37
-
https://www.vistagen.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.